Mark Vincent

11.0k citations
171 papers · 6.5k indexed · 2 hit papers · h-index 38

Mark Vincent

165 papers receiving 6.3k citations

Hit Papers

Randomized Phase III Study of Cisplatin With or Without R...474200020262008201750010001.5k

Peers

Mark Vincent
Comparison fields: 5 of 138
  • Oncology 3.8k
  • Pulmonary and Respiratory Medicine 3.7k
  • Cancer Research 723
  • Hepatology 206
  • Molecular Biology 1.5k
Replace Petr Zatloukal with:
Petr Zatloukal Czechia
Philip Bonomi United States
George R. Simon United States
Ikuo Sekine Japan
Alan B. Sandler United States
Stephen L. Graziano United States
Thomas E. Stinchcombe United States
Jyoti D. Patel United States
Nagio Takigawa Japan
K. Mattson Finland
Mark Vincent relative to Petr Zatloukal Czechia Petr Zatloukal's profile →
Citations per field
00.5×1.5×1.9×
Petr Zatloukal · 1×
Citations per year

Countries citing papers authored by Mark Vincent

Since Specialization
Citations

This map shows the geographic impact of Mark Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Vincent more than expected).

Fields of papers citing papers by Mark Vincent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Vincent. The network helps show where Mark Vincent may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Vincent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Vincent Line = papers co-authored together Mark Vincent links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20243
4 20245
5 20231
6 20230
7 202310
8 20219
9 20181
10 20167
11 20084
12 2007109
13 200132
14
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapybreakdown →
20001717
15 200027
16 199932
17 199916
18 199543
19 198844
20 198514

About Mark Vincent

Mark Vincent is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Biological Psychiatry and Hematology, having authored 171 papers that have together received 6.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (43 papers), Colorectal Cancer Treatments and Studies (42 papers), Lung Cancer Research Studies (31 papers), Lung Cancer Diagnosis and Treatment (26 papers), Cancer Treatment and Pharmacology (19 papers), Gastric Cancer Management and Outcomes (18 papers), Cancer Genomics and Diagnostics (14 papers) and Genetic factors in colorectal cancer (11 papers). The work is most often cited by research in Oncology (3.8k citations), Pulmonary and Respiratory Medicine (3.7k citations), Cancer Research (723 citations), Hepatology (206 citations) and Molecular Biology (1.5k citations). Mark Vincent has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Frances A. Shepherd, Ronald L. Burkes, Janet Dancey, J. Bérille, Susan Coughlin, Yong Kim, Laurent Gressot, K. Mattson, Nathan Levitan and Richard J. Gralla. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Lung Cancer, European Journal of Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026